AH-TP1-23-001: Advancing Equity in Adolescent Health through Evidence-Based Teen Pregnancy Prevention Programs and Services
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of the Assistant Secretary for Health notices from 2023.
Office of the Assistant Secretary for Health offered grants of up to $2.0 million (at least $350,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 70 awards worth $68.6 million in total. Applications closed on April 18, 2023.
From the official notice on Grants.gov, last changed February 14, 2023. Checked November 7, 2026.
- Award ceiling$2.0 million
- Award floor$350,000
- Total funding$68.6 million
- Expected awards70
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | February 14, 2023 |
|---|---|
| Deadline | April 18, 2023 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
Is this a realistic fit?
- Past Teenage Pregnancy Prevention Program awards averaged $2.8 million; this notice allows up to $2.0 million per award.
- Most of the program's money (70% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The primary focus of OASH is leading America to healthier lives, especially for those who have suffered historic disparities. In support of this vision, OPA promotes health across the reproductive lifespan through innovative, evidence-based sexual and reproductive health and family planning programs, services, strategic partnerships, evaluation, and research. The Teen Pregnancy Prevention (TPP) Program is a national, evidence-based program that funds diverse organizations working to reach adolescents to improve sexual and reproductive health outcomes and promote positive youth development. The Office of Population Affairs (OPA) anticipates FY2023 funds being available to support cooperative agreements for organizations to advance health equity for adolescents, their family, and communities through the replication and scaling of medically accurate and age appropriate evidence-based teen pregnancy prevention programs that have been proven effective through rigorous evaluation to reduce teenage pregnancy, behavioral risk factors underlying teenage pregnancy, or other associated risk factors. Evidence-based program are programs that have been proven effective through rigorous evaluation to reduce teenage pregnancy, behavioral risk factors underlying teenage pregnancy, or other associated risk factors. OPA aims to equitably bolster adolescent health outcomes and mitigate disparities through evidence-based teen pregnancy prevention programs and services. Anticipated funds will be used to serve communities and populations with the greatest needs and facing significant disparities to advance equity in adolescent health through the replication of evidence-based teen pregnancy prevention programs and services.
Who has won Teenage Pregnancy Prevention Program grants before
From fiscal 2021 to 2025, Teenage Pregnancy Prevention Program (93.297) awarded $439 million across 155 grant awards, an average of $2.8 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Education Training & Research Associates | California | 4 | $15.0 million |
| The Morehouse School of Medicine, Inc. | Georgia | 3 | $12.4 million |
| Child Trends, Incorporated | Maryland | 4 | $11.5 million |
| Policy and Research L.L.C. | Louisiana | 3 | $11.5 million |
| Fact Forward | South Carolina | 3 | $10.3 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is AH-TP1-23-001 still open?
No. It closed on April 18, 2023.
Who can apply for Advancing Equity in Adolescent Health through Evidence-Based Teen Pregnancy Prevention Programs and Services?
Office of the Assistant Secretary for Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
What is the deadline for Advancing Equity in Adolescent Health through Evidence-Based Teen Pregnancy Prevention Programs and Services?
Closed April 18, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $2.0 million each. About $68.6 million in total across about 70 awards.
Who has won Teenage Pregnancy Prevention Program grants before?
The largest recipients over five fiscal years were Education Training & Research Associates, The Morehouse School of Medicine, Inc., Child Trends, Incorporated. The program made 155 awards worth $439 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)